Charles River Laboratories International Inc
NYSE:CRL
Charles River Laboratories International Inc
Cash from Operating Activities
Charles River Laboratories International Inc
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Charles River Laboratories International Inc
NYSE:CRL
|
Cash from Operating Activities
$683.9m
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash from Operating Activities
$8.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
Danaher Corp
NYSE:DHR
|
Cash from Operating Activities
$7B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
12%
|
CAGR 10-Years
7%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash from Operating Activities
$965.9m
|
CAGR 3-Years
10%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash from Operating Activities
$2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
13%
|
CAGR 10-Years
6%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash from Operating Activities
$2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
19%
|
See Also
What is Charles River Laboratories International Inc's Cash from Operating Activities?
Cash from Operating Activities
683.9m
USD
Based on the financial report for Dec 30, 2023, Charles River Laboratories International Inc's Cash from Operating Activities amounts to 683.9m USD.
What is Charles River Laboratories International Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
13%
Over the last year, the Cash from Operating Activities growth was 10%. The average annual Cash from Operating Activities growth rates for Charles River Laboratories International Inc have been 8% over the past three years , 9% over the past five years , and 13% over the past ten years .